US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Compugen

1.44

-0.0400-2.70%

Post-market: 1.440.00000.00%18:37 EDT

Volume:75.28K

Turnover:108.60K

Market Cap:134.66M

PE:-9.00

High:1.47

Open:1.44

Low:1.42

Close:1.48

Loading ...

Overview Company News Filings

Compugen Advances COM503 to Phase 1 Clinical Trial in Cancer Treatment

Compugen Announces First Patient Dosed in Phase 1 Clinical Trial to Evaluate COM503 as Monotherapy and in Combination with Zimberelimab in Advanced Solid Tumors

The past five years for Compugen (NASDAQ:CGEN) investors has not been profitable

Simply Wall St.

Compugen Bolsters Cancer Therapy Portfolio with New Patent

Compugen Expands its Intellectual Property Portfolio with New U.S. Patent Covering Triple Combination Use of COM902 (reduced Fc anti-TIGIT) with anti-PD-1 and anti-PVRIG Antibodies

Compugen Ltd. (NASDAQ:CGEN) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?

Simply Wall St.

Compugen Ltd (CGEN) Q3 2024 Earnings Call Highlights: Promising Developments and Strategic ...

Compugen (CGEN) Q3 Earnings and Revenues Lag Estimates

Compugen Ltd reports results for the quarter ended September 30 - Earnings Summary

Compugen’s Financial Surge and Promising Drug Trials

Compugen: Q3 Earnings Snapshot

Associated Press Finance

Compugen Q3 2024 GAAP EPS $0.01 Misses $0.06 Estimate, Sales $17.132M Miss $17.862M Estimate

Press Release: Compugen Reports Third Quarter 2024 Results

Compugen to Participate in Stifel 2024 Healthcare Conference

Compugen Ltd expected to post earnings of 11 cents a share - Earnings Preview

Compugen to Present Anti-Tumor Activity and Safety Data of COM701, COM902 and Pembrolizumab Combination in Patients with Platinum Resistant Ovarian Cancer at SITC 2024

Compugen to Release Third Quarter 2024 Financial Results on Tuesday, November 12, 2024

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/CGEN/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CGEN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CGEN\",,,,,undefined,":{"symbol":"CGEN","market":"US","secType":"STK","nameCN":"Compugen","latestPrice":1.44,"timestamp":1745870400000,"preClose":1.48,"halted":0,"volume":75275,"hourTrading":{"tag":"盘后","latestPrice":1.44,"preClose":1.44,"latestTime":"18:37 EDT","volume":27,"amount":38.62,"timestamp":1745879871501},"delay":0,"floatShares":91600791,"shares":93512982,"eps":-0.16,"marketStatus":"Not Yet Opened","change":-0.04,"latestTime":"04-28 16:00:00 EDT","open":1.44,"high":1.47,"low":1.42,"amount":108603.111635,"amplitude":0.033784,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.16,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745913600000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":965966400000,"exchange":"NASDAQ","adjPreClose":1.48,"preHourTrading":{"tag":"盘前","latestPrice":1.44,"preClose":1.48,"latestTime":"09:27 EDT","volume":509,"amount":734.0999564,"timestamp":1745846850282},"postHourTrading":{"tag":"盘后","latestPrice":1.44,"preClose":1.44,"latestTime":"18:37 EDT","volume":27,"amount":38.62,"timestamp":1745879871501},"volumeRatio":0.655163,"impliedVol":1.3596,"impliedVolPercentile":0.42},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CGEN\",,,,,undefined,":{"symbol":"CGEN","floatShares":91600791,"roa":"-7.88%","roe":"-23.63%","lyrEps":-0.158955,"volumeRatio":0.655163,"shares":93512982,"dividePrice":0,"high":1.47,"amplitude":0.033784,"preClose":1.48,"low":1.42,"week52Low":1.13,"pbRate":"2.45","psRate":"4.83","week52High":2.66,"institutionHeld":0.1545,"latestPrice":1.44,"eps":-0.16,"divideRate":0,"volume":75275,"delay":0,"ttmEps":-0.16,"open":1.44,"prevYearClose":1.53,"prevWeekClose":1.48,"prevMonthClose":1.46,"prevQuarterClose":1.46,"fiveDayClose":1.39,"twentyDayClose":1.53,"sixtyDayClose":2.35},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CGEN\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2501011726","title":"Compugen Advances COM503 to Phase 1 Clinical Trial in Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2501011726","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501011726?lang=en_us&edition=fundamental","pubTime":"2025-01-08 20:28","pubTimestamp":1736339332,"startTime":"0","endTime":"0","summary":"Compugen ( ($CGEN) ) has provided an announcement. Compugen has initiated a Phase 1 clinical trial for COM503, a novel anti-IL-18 binding protein a...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/compugen-advances-com503-to-phase-1-clinical-trial-in-cancer-treatment?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/compugen-advances-com503-to-phase-1-clinical-trial-in-cancer-treatment?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CGEN","BK4121"],"gpt_icon":0},{"id":"2501572965","title":"Compugen Announces First Patient Dosed in Phase 1 Clinical Trial to Evaluate COM503 as Monotherapy and in Combination with Zimberelimab in Advanced Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2501572965","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501572965?lang=en_us&edition=fundamental","pubTime":"2025-01-08 20:00","pubTimestamp":1736337600,"startTime":"0","endTime":"0","summary":"New approach to harnesscytokine biology to treat cancer patients advances to the clinic. First patient dosed with potential first-in-class anti-IL-18 binding protein antibody, COM503, licensed to Gilead Sciences, Inc.Phase 1 dose escalation and dose expansion trial to assess the safety and tolerability of COM503 as monotherapy and in combination for patients with advanced solid tumors. Compugen responsible for running the Phase 1 trial. This Phase 1 multi-center dose escalation and dose expansion trial will evaluate the safety, tolerability, and pharmacokinetics of COM503 as monotherapy and in combination with Gilead's anti-PD1, zimberelimab in patients with advanced solid tumors. The trial was initiated in the fourth quarter of 2024 as planned.The primary objectives of this trial are to assess the safety and tolerability of COM503 as a monotherapy and in combination with zimberelimab in patients with advanced solid tumors and to identify the maximum tolerated dose /maximum administere","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/compugen-announces-first-patient-dosed-120000398.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/compugen-announces-first-patient-dosed-120000398.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE0031619046.USD","BK4157","BK4139","IE00B7SZL793.SGD","CGEN","IE00B66KJ199.SGD","IE00B19Z4B17.USD","BK4121","AEIS"],"gpt_icon":0},{"id":"2494863932","title":"The past five years for Compugen (NASDAQ:CGEN) investors has not been profitable","url":"https://stock-news.laohu8.com/highlight/detail?id=2494863932","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2494863932?lang=en_us&edition=fundamental","pubTime":"2024-12-26 21:01","pubTimestamp":1735218119,"startTime":"0","endTime":"0","summary":"We're definitely into long term investing, but some companies are simply bad investments over any time frame. It hits us in the gut when we see fellow investors suffer a loss. Spare a thought for those who held Compugen Ltd.  for five whole years - as the share price tanked 74%. The falls have accelerated recently, with the share price down 11% in the last three months.So let's have a look and see if the longer term performance of the company has been in line with the underlying business' progress.To quote Buffett, 'Ships will sail around the world but the Flat Earth Society will flourish. There will continue to be wide discrepancies between price and value in the marketplace...' One imperfect but simple way to consider how the market perception of a company has shifted is to compare the change in the earnings per share  with the share price movement.Compugen became profitable within the last five years. Most would consider that to be a good thing, so it's counter-intuitive to see the ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/past-five-years-compugen-nasdaq-130159619.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["QID","IE00BGHQF748.EUR","CGEN","IE00B64PRP62.GBP","QLD","NQmain","BK4121","SQQQ","MNQmain","PSQ","BK4585",".IXIC","BK4139","BK4588","LU2210150020.SGD","IE00BKPKM429.USD","TQQQ","BK4112","USAW.SI","USJW.SI","IE00B3QW5Z07.USD","LU2095319765.USD","LU2210149790.SGD","NVIW.SI","TSYW.SI","NDAQ"],"gpt_icon":1},{"id":"2486722825","title":"Compugen Bolsters Cancer Therapy Portfolio with New Patent","url":"https://stock-news.laohu8.com/highlight/detail?id=2486722825","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486722825?lang=en_us&edition=fundamental","pubTime":"2024-11-27 20:32","pubTimestamp":1732710727,"startTime":"0","endTime":"0","summary":"Compugen (CGEN) has released an update. Compugen Ltd. has secured a new U.S. patent for its innovative cancer treatment approach, involving the com...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/compugen-bolsters-cancer-therapy-portfolio-with-new-patent?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/compugen-bolsters-cancer-therapy-portfolio-with-new-patent?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CGEN","BK4121"],"gpt_icon":0},{"id":"2486182328","title":"Compugen Expands its Intellectual Property Portfolio with New U.S. Patent Covering Triple Combination Use of COM902 (reduced Fc anti-TIGIT) with anti-PD-1 and anti-PVRIG Antibodies","url":"https://stock-news.laohu8.com/highlight/detail?id=2486182328","media":"PR Newswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486182328?lang=en_us&edition=fundamental","pubTime":"2024-11-27 20:00","pubTimestamp":1732708800,"startTime":"0","endTime":"0","summary":"Broad method of use patent protection for COM902, a potential best-in-class reducedFc, clinical stage, anti-TIGIT antibody, in triple combination with any anti-PD-1 antibody and any anti-PVRIG antibody for the treatment of cancer. Further strengthens Compugen's IP portfolio across DNAM-1 axis checkpoint inhibitors. U.S. Patent No. 12152084titled \"Triple combination antibody therapies\" augments patents previously issued to Compugen by expanding and protecting the use of COM902 and backup antibodies for treating cancer patients, to include the triplet combination of COM902 with any anti-PD-1 antibody and any anti-PVRIG antibody.About Compugen Compugenis a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery platform  to identify new drug targets and biological pathways for developing cancer immunotherapies. Compugen has two proprietary product candidates in Phase 1 development: COM701, a potential first-in-class ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/IUUJmPAkOjOs1FRPW9j7xA--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/3879a9583d5053e9150b9de6ded803b1","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/IUUJmPAkOjOs1FRPW9j7xA--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/3879a9583d5053e9150b9de6ded803b1"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/compugen-expands-intellectual-property-portfolio-120000658.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/compugen-expands-intellectual-property-portfolio-120000658.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PD","CGEN","LU1169590202.USD","BK4121","BK4023","LU1169589451.USD","BK4139"],"gpt_icon":0},{"id":"2483328351","title":"Compugen Ltd. (NASDAQ:CGEN) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?","url":"https://stock-news.laohu8.com/highlight/detail?id=2483328351","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483328351?lang=en_us&edition=fundamental","pubTime":"2024-11-15 18:11","pubTimestamp":1731665470,"startTime":"0","endTime":"0","summary":"Compugen  has had a rough three months with its share price down 19%. But if you pay close attention, you might find that its key financial indicators look quite decent, which could mean that the stock could potentially rise in the long-term given how markets usually reward more resilient long-term fundamentals. Specifically, we decided to study Compugen's  ROE in this article.ROE or return on equity is a useful tool to assess how effectively a company can generate returns on the investment it received from its shareholders. Put another way, it reveals the company's success at turning shareholder investments into profits.Return on Equity = Net Profit  ÷ Shareholders' Equity","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/qUsXHnhTq9BjFq.vX6I3sw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/b7362375b2727bfdfe4eb144bcc3fe6a","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/qUsXHnhTq9BjFq.vX6I3sw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/b7362375b2727bfdfe4eb144bcc3fe6a"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/compugen-ltd-nasdaq-cgen-stocks-101110360.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SQQQ",".IXIC","MNQmain","BK4139","LU2095319765.USD","BK4585","QLD","BK4588","IE00B64PRP62.GBP","NDAQ","IE00B3QW5Z07.USD","LU2210149790.SGD","IE00BKPKM429.USD","QID","NQmain","TQQQ","IE00BGHQF748.EUR","BK4121","LU2210150020.SGD","CGEN","PSQ","BK4112"],"gpt_icon":1},{"id":"2483263350","title":"Compugen Ltd (CGEN) Q3 2024 Earnings Call Highlights: Promising Developments and Strategic ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2483263350","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483263350?lang=en_us&edition=fundamental","pubTime":"2024-11-13 15:08","pubTimestamp":1731481709,"startTime":"0","endTime":"0","summary":"For the complete transcript of the earnings call, please refer to the full earnings call transcript.Compugen Ltd  reported encouraging data from their studies on COM701, COM902, and pembrolizumab in patients with platinum-resistant ovarian cancer, showing durable responses and good tolerability.The company received a $30 million milestone payment from Gilead for achieving FDA IND clearance for COM503, indicating strong progress in their partnership.The company plans to initiate a new trial in Q2 2025, targeting relapsed platinum-sensitive ovarian cancer patients, which could open new regulatory and commercial opportunities.The overall response rate in the platinum-resistant ovarian cancer study was only 17%, which may be considered low despite the challenging patient population.The company faces competition in the ovarian cancer treatment landscape, particularly in maintenance therapy for relapsed platinum-sensitive patients.The development of biomarkers for patient selection remains c","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/wuUdaKN7zdW6cCre6G7xGA--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/0a7bbbdd139a46e42ccbda2c406c22d6","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/wuUdaKN7zdW6cCre6G7xGA--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/0a7bbbdd139a46e42ccbda2c406c22d6"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/compugen-ltd-cgen-q3-2024-070829850.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CGEN"],"gpt_icon":0},{"id":"2483034410","title":"Compugen (CGEN) Q3 Earnings and Revenues Lag Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2483034410","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483034410?lang=en_us&edition=fundamental","pubTime":"2024-11-13 00:05","pubTimestamp":1731427502,"startTime":"0","endTime":"0","summary":"Compugen  came out with quarterly earnings of $0.01 per share, missing the Zacks Consensus Estimate of $0.06 per share. This compares to loss of $0.11 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -83.33%. A quarter ago, it was expected that this drug developer would post a loss of $0.08 per share when it actually produced a loss of $0.02, delivering a surprise of 75%.Over the last four quarters, the company has surpassed consensus EPS estimates three times.Compugen , which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $17.13 million for the quarter ended September 2024, missing the Zacks Consensus Estimate by 3.05%. This compares to zero revenues a year ago.Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Medical - Biomedical and Genetic","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/AwCmIhR0z9Bg4cEkwuNQjw--~B/aD02MDE7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/8442d24e11d454aa89061259a9714d43","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/AwCmIhR0z9Bg4cEkwuNQjw--~B/aD02MDE7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/8442d24e11d454aa89061259a9714d43"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/compugen-cgen-q3-earnings-revenues-160502359.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CGEN"],"gpt_icon":0},{"id":"2482082833","title":"Compugen Ltd reports results for the quarter ended September 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2482082833","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482082833?lang=en_us&edition=fundamental","pubTime":"2024-11-12 23:34","pubTimestamp":1731425695,"startTime":"0","endTime":"0","summary":"Compugen Ltd reports results for the quarter ended September 30 - Earnings SummaryCompugen Ltd CGEN.OQ reported quarterly adjusted earnings of 1 cent per share for the quarter ended September 30, high","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241112:nL8N3MJ28I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CGEN"],"gpt_icon":0},{"id":"2482824900","title":"Compugen’s Financial Surge and Promising Drug Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2482824900","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482824900?lang=en_us&edition=fundamental","pubTime":"2024-11-12 23:32","pubTimestamp":1731425568,"startTime":"0","endTime":"0","summary":"Compugen (CGEN) has released an update. Compugen reported strong third-quarter financial results for 2024, with a net profit of $1.3 million, a sig...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/compugens-financial-surge-and-promising-drug-trials?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/compugens-financial-surge-and-promising-drug-trials?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4121","CGEN"],"gpt_icon":0},{"id":"2482863084","title":"Compugen: Q3 Earnings Snapshot","url":"https://stock-news.laohu8.com/highlight/detail?id=2482863084","media":"Associated Press Finance","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482863084?lang=en_us&edition=fundamental","pubTime":"2024-11-12 22:56","pubTimestamp":1731423381,"startTime":"0","endTime":"0","summary":"HOLON, Israel  — HOLON, Israel  — Compugen Ltd.  on Tuesday reported net income of $1.3 million in its third quarter.The Holon, Israel-based company said it had net income of 1 cent per share.The drug developer posted revenue of $17.1 million in the period.The company's shares closed at $1.74. A year ago, they were trading at 60 cents.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/compugen-q3-earnings-snapshot-145621911.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CGEN"],"gpt_icon":0},{"id":"2482703888","title":"Compugen Q3 2024 GAAP EPS $0.01 Misses $0.06 Estimate, Sales $17.132M Miss $17.862M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2482703888","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482703888?lang=en_us&edition=fundamental","pubTime":"2024-11-12 20:08","pubTimestamp":1731413305,"startTime":"0","endTime":"0","summary":"Compugen (NASDAQ:CGEN) reported quarterly earnings of $0.01 per share which missed the analyst consensus estimate of $0.06 by 83.33 percent.  The company reported quarterly sales of $17.132 million which missed the","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/11/41896696/compugen-q3-2024-gaap-eps-0-01-misses-0-06-estimate-sales-17-132m-miss-17-862m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Compugen Q3 2024 GAAP EPS $0.01 Misses $0.06 Estimate, Sales $17.132M Miss $17.862M Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CGEN"],"gpt_icon":0},{"id":"2482082677","title":"Press Release: Compugen Reports Third Quarter 2024 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2482082677","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482082677?lang=en_us&edition=fundamental","pubTime":"2024-11-12 20:00","pubTimestamp":1731412800,"startTime":"0","endTime":"0","summary":"-- Clinical data presented at SITC 2024 demonstrated COM701 . mediated anti-tumor activity with durable responses and good tolerability. profile in tumors typically not responding to immunotherapy, aligned with. -- Plans to initiate, in Q2 2025, an adaptive platform trial in patients. with relapsed platinum sensitive ovarian cancer in the maintenance. setting, to evaluate single agent COM701 and future combinations. representing an unmet need and regulatory and commercial opportunity. -- On track to initiate Phase 1 trial evaluating COM503  in. -- Partner AstraZeneca reported encouraging rilvegostomig data at WCLC and. ESMO 2024 and advanced rilvegostomig into two additional Phase 3 lung. -- Solid balance sheet with expected cash runway into 2027 anticipated to. reach potential key catalysts, including projected COM701 sub-study 1. interim analysis and support advancement of COM503 in the clinic. HOLON, Israel, Nov. 12, 2024 /PRNewswire/ -- Compugen Ltd.   a clinical-stage cancer immun","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TM","03160","BK4121","BK4555","BK4585","BK4588","CGEN","PROC","BK4139","BK4007","BK4099"],"gpt_icon":0},{"id":"2482200059","title":"Compugen to Participate in Stifel 2024 Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2482200059","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482200059?lang=en_us&edition=fundamental","pubTime":"2024-11-11 20:00","pubTimestamp":1731326400,"startTime":"0","endTime":"0","summary":"HOLON, Israel, Nov. 11, 2024 /PRNewswire/ --Compugen Ltd.  a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, todayannounced that Compugen management will participate in a fireside chat at the upcoming Stifel 2024 Healthcare Conference in New York City. The fireside chat will take place on Monday, November 18, 2024 at 8:35 am ET.A live webcast will be accessible on the Investor Relations section of the Compugen website atwww.cgen.com. A replay will also be available following the live event.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/JyCb2X3IxpMtBRGBNdho9A--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/5d13142718d21c50cbe9bbba66ccb4fe","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/JyCb2X3IxpMtBRGBNdho9A--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/5d13142718d21c50cbe9bbba66ccb4fe"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/compugen-participate-stifel-2024-healthcare-120000391.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/compugen-participate-stifel-2024-healthcare-120000391.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CGEN","BK4137","BK4127","SF","BK4121","HCSG","BK4139"],"gpt_icon":0},{"id":"2482487744","title":"Compugen Ltd  expected to post earnings of 11 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2482487744","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482487744?lang=en_us&edition=fundamental","pubTime":"2024-11-09 01:19","pubTimestamp":1731086350,"startTime":"0","endTime":"0","summary":"Compugen Ltd  expected to post earnings of11cents a share - Earnings Preview Compugen Ltd CGEN.OQ, CGEN.O is expected to show a rise in quarterly revenue when it reports  results on November 12 for th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241108:nL8N3MF31G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CGEN"],"gpt_icon":0},{"id":"2481027355","title":"Compugen to Present Anti-Tumor Activity and Safety Data of COM701, COM902 and Pembrolizumab Combination in Patients with Platinum Resistant Ovarian Cancer at SITC 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2481027355","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481027355?lang=en_us&edition=fundamental","pubTime":"2024-11-05 22:00","pubTimestamp":1730815200,"startTime":"0","endTime":"0","summary":"HOLON, ISRAEL, Nov. 5, 2024 /PRNewswire/ --Compugen Ltd.  a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, todayannounced that data supporting the anti-tumor activity and safety profile of the triple combination COM701, COM902 and pembrolizumab in advanced heavily pre-treated patients with platinum resistant ovarian cancer  has been published as an abstract released by the Society for Immunotherapy of Cancer .Dr. Cohen-Dayag continued, \"Our development path in earlier lines of ovarian cancer will start by addressing this unmet need. I look forward to discussing these data and our future development plans including a fireside chat with Dr. Yeku, as part of ou","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/E.7ETgtAltXYykjXlUSn7w--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/efcd311e2b87fc584da495f759a4dcfc","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/E.7ETgtAltXYykjXlUSn7w--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/efcd311e2b87fc584da495f759a4dcfc"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/compugen-present-anti-tumor-activity-140000263.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/compugen-present-anti-tumor-activity-140000263.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CGEN","BK4007","SITC","BK4231","BK4121","PROC","BK4080","BK4139"],"gpt_icon":0},{"id":"2479477521","title":"Compugen to Release Third Quarter 2024 Financial Results on Tuesday, November 12, 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2479477521","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479477521?lang=en_us&edition=fundamental","pubTime":"2024-10-29 19:00","pubTimestamp":1730199600,"startTime":"0","endTime":"0","summary":"HOLON, Israel, Oct. 29, 2024 /PRNewswire/ --Compugen Ltd.  a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced, that it will release its third quarter 2024 financial results on Tuesday, November 12, 2024, before the U.S. financial markets open. Management will host a conference call and webcast to review the financial results and provide a corporate update at 8:30 am ET.As part of the update, management will discuss Compugen's data that will have been presented at the Annual Meeting of the Society for Immunotherapy of Cancer, being held on November 8-10, 2024.To access the live conference call by telephone, please dial 1-866-744-5399 from the U.S.,or +972-3-918-0644 internationally. The call will be available via live webcast through Compugen's website, located at the following link.Following the live webcast, a replay will be available on the Company's website.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/8EqRovf0Lo_crTB1FRQiGQ--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/d6aa56cf087924c71f4f3dc3d9cb44bf","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/8EqRovf0Lo_crTB1FRQiGQ--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/d6aa56cf087924c71f4f3dc3d9cb44bf"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/compugen-release-third-quarter-2024-110000806.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/compugen-release-third-quarter-2024-110000806.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4121","BK4139","CGEN"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":37,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CGEN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-04","symbol":"CGEN","fiscalQuarterEnding":"2024/12","expectedEps":0.07,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1741064400000,"reportTimeType":"pre","actualEps":-0.07},{"market":"US","date":"2024-11-12","symbol":"CGEN","fiscalQuarterEnding":"2024/09","expectedEps":0.06,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":0.01},{"market":"US","date":"2024-08-06","symbol":"CGEN","fiscalQuarterEnding":"2024/06","expectedEps":-0.08,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1722916800000,"reportTimeType":"pre","actualEps":-0.02},{"market":"US","date":"2024-05-20","symbol":"CGEN","fiscalQuarterEnding":"2024/03","expectedEps":-0.1,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1716177600000,"reportTimeType":"pre","actualEps":-0.08},{"market":"US","date":"2024-03-05","symbol":"CGEN","fiscalQuarterEnding":"2023/12","expectedEps":0.1,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1709614800000,"reportTimeType":"pre","actualEps":0.11}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CGEN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CGEN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.75,"buy":0.25,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.75,"analysts":4,"updateTime":1736827200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CGEN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CGEN","date":"2025-04-25","current":-9.725192,"percent":0.475223,"low":-61.215712,"twenty":-23.369267,"median":-9.168959,"eighty":-2.170365,"high":143.907836,"avg":-8.251165,"sd":32.255769,"marketCap":138399213},"quantilePoints":[{"date":"2020-05-01","current":-38.893122,"twenty":-15.729715,"median":-9.744333,"eighty":-6.228791,"marketCap":1063221269},{"date":"2020-05-08","current":-45.383225,"twenty":-15.729715,"median":-9.744333,"eighty":-6.228791,"marketCap":1182550686},{"date":"2020-05-15","current":-37.390763,"twenty":-15.729715,"median":-9.744333,"eighty":-6.228791,"marketCap":974291114},{"date":"2020-05-22","current":-43.536356,"twenty":-15.729715,"median":-9.744333,"eighty":-6.228791,"marketCap":1134426838},{"date":"2020-05-29","current":-46.822119,"twenty":-15.729715,"median":-9.744333,"eighty":-6.228791,"marketCap":1220043958},{"date":"2020-06-05","current":-41.406695,"twenty":-15.729715,"median":-9.744333,"eighty":-6.228791,"marketCap":1078934260},{"date":"2020-06-12","current":-42.319407,"twenty":-15.729715,"median":-9.744333,"eighty":-6.228791,"marketCap":1102716794},{"date":"2020-06-19","current":-47.248051,"twenty":-15.729715,"median":-9.744333,"eighty":-6.228791,"marketCap":1231142473},{"date":"2020-06-26","current":-44.388221,"twenty":-15.729715,"median":-9.744333,"eighty":-6.228791,"marketCap":1156623869},{"date":"2020-07-02","current":-46.852543,"twenty":-15.729715,"median":-9.744333,"eighty":-6.228791,"marketCap":1220836709},{"date":"2020-07-10","current":-48.252034,"twenty":-15.729715,"median":-9.744333,"eighty":-6.228791,"marketCap":1257303260},{"date":"2020-07-17","current":-48.70839,"twenty":-15.729715,"median":-9.744333,"eighty":-6.228791,"marketCap":1269194527},{"date":"2020-07-24","current":-43.064789,"twenty":-15.729715,"median":-9.744333,"eighty":-6.228791,"marketCap":1122139196},{"date":"2020-07-31","current":-45.264132,"twenty":-15.729715,"median":-9.744333,"eighty":-6.228791,"marketCap":1191623551},{"date":"2020-08-07","current":-51.396019,"twenty":-15.729715,"median":-9.744333,"eighty":-6.228791,"marketCap":1353051609},{"date":"2020-08-14","current":-54.134203,"twenty":-15.729715,"median":-9.744333,"eighty":-6.228791,"marketCap":1425137028},{"date":"2020-08-21","current":-59.579097,"twenty":-15.729715,"median":-9.744333,"eighty":-6.228791,"marketCap":1568479299},{"date":"2020-08-28","current":-53.095582,"twenty":-15.735417,"median":-9.744333,"eighty":-6.228791,"marketCap":1397794283},{"date":"2020-09-04","current":-48.657836,"twenty":-15.735417,"median":-9.744333,"eighty":-6.228791,"marketCap":1280966189},{"date":"2020-09-11","current":-49.098463,"twenty":-15.735417,"median":-9.744333,"eighty":-6.228791,"marketCap":1292566142},{"date":"2020-09-18","current":-59.358783,"twenty":-15.735417,"median":-9.744333,"eighty":-6.228791,"marketCap":1562679323},{"date":"2020-09-25","current":-50.640659,"twenty":-15.735417,"median":-9.744333,"eighty":-6.228791,"marketCap":1333165976},{"date":"2020-10-02","current":-47.792318,"twenty":-15.735417,"median":-9.744333,"eighty":-6.228791,"marketCap":1258180568},{"date":"2020-10-09","current":-55.172824,"twenty":-15.735417,"median":-9.744333,"eighty":-6.228791,"marketCap":1452479774},{"date":"2020-10-16","current":-49.759404,"twenty":-15.735417,"median":-9.744333,"eighty":-6.228791,"marketCap":1309966071},{"date":"2020-10-23","current":-44.566297,"twenty":-15.735417,"median":-9.744333,"eighty":-6.228791,"marketCap":1173252344},{"date":"2020-10-30","current":-40.569179,"twenty":-15.735417,"median":-9.744333,"eighty":-6.228791,"marketCap":1068024203},{"date":"2020-11-06","current":-39.212562,"twenty":-15.755018,"median":-9.744333,"eighty":-6.228791,"marketCap":1082109860},{"date":"2020-11-13","current":-40.503634,"twenty":-15.755018,"median":-9.744333,"eighty":-6.228791,"marketCap":1117738285},{"date":"2020-11-20","current":-39.692961,"twenty":-15.755018,"median":-9.744333,"eighty":-6.228791,"marketCap":1095366948},{"date":"2020-11-27","current":-39.032412,"twenty":-15.755018,"median":-9.744333,"eighty":-6.228791,"marketCap":1077138452},{"date":"2020-12-04","current":-38.101639,"twenty":-15.755018,"median":-9.744333,"eighty":-6.228791,"marketCap":1051452842},{"date":"2020-12-11","current":-37.351016,"twenty":-15.755018,"median":-9.744333,"eighty":-6.228791,"marketCap":1030738641},{"date":"2020-12-18","current":-38.04159,"twenty":-15.865992,"median":-9.744333,"eighty":-6.228791,"marketCap":1049795706},{"date":"2020-12-24","current":-39.422736,"twenty":-15.942842,"median":-9.744333,"eighty":-6.228791,"marketCap":1087909836},{"date":"2020-12-31","current":-36.360193,"twenty":-16.016962,"median":-9.744333,"eighty":-6.228791,"marketCap":1003395896},{"date":"2021-01-08","current":-39.99321,"twenty":-16.195161,"median":-9.744333,"eighty":-6.228791,"marketCap":1103652629},{"date":"2021-01-15","current":-39.062437,"twenty":-16.348128,"median":-9.744333,"eighty":-6.228791,"marketCap":1077967020},{"date":"2021-01-22","current":-37.651265,"twenty":-16.46747,"median":-9.744333,"eighty":-6.228791,"marketCap":1039024322},{"date":"2021-01-29","current":-36.510318,"twenty":-16.768442,"median":-9.744333,"eighty":-6.228791,"marketCap":1007538736},{"date":"2021-02-05","current":-38.942338,"twenty":-17.45912,"median":-9.744333,"eighty":-6.228791,"marketCap":1074652747},{"date":"2021-02-12","current":-39.422736,"twenty":-18.250158,"median":-9.744333,"eighty":-6.228791,"marketCap":1087909836},{"date":"2021-02-19","current":-38.341839,"twenty":-18.729014,"median":-9.744333,"eighty":-6.228791,"marketCap":1058081387},{"date":"2021-02-26","current":-26.288313,"twenty":-20.003328,"median":-9.744333,"eighty":-6.228791,"marketCap":780710319},{"date":"2021-03-05","current":-23.372085,"twenty":-20.463667,"median":-9.744333,"eighty":-6.228791,"marketCap":694104190},{"date":"2021-03-12","current":-25.07674,"twenty":-21.647526,"median":-9.744333,"eighty":-6.228791,"marketCap":744729029},{"date":"2021-03-19","current":-25.640262,"twenty":-22.700491,"median":-9.744333,"eighty":-6.228791,"marketCap":761464512},{"date":"2021-03-26","current":-22.963532,"twenty":-23.024415,"median":-9.744333,"eighty":-6.228791,"marketCap":681970964},{"date":"2021-04-01","current":-24.738627,"twenty":-23.157947,"median":-9.744333,"eighty":-6.228791,"marketCap":734687738},{"date":"2021-04-09","current":-23.724287,"twenty":-23.724287,"median":-9.744333,"eighty":-6.228791,"marketCap":704563867},{"date":"2021-04-16","current":-24.146928,"twenty":-23.762158,"median":-9.744333,"eighty":-6.228791,"marketCap":717115480},{"date":"2021-04-23","current":-24.597746,"twenty":-23.890949,"median":-9.744333,"eighty":-6.228791,"marketCap":730503867},{"date":"2021-04-30","current":-24.315985,"twenty":-24.214551,"median":-9.744333,"eighty":-6.228791,"marketCap":722136125},{"date":"2021-05-07","current":-21.371581,"twenty":-24.214551,"median":-9.744333,"eighty":-6.228791,"marketCap":634693223},{"date":"2021-05-14","current":-20.613375,"twenty":-24.214551,"median":-9.744333,"eighty":-6.228791,"marketCap":669419352},{"date":"2021-05-21","current":-20.381474,"twenty":-24.214551,"median":-9.744333,"eighty":-6.228791,"marketCap":661888384},{"date":"2021-05-28","current":-19.78884,"twenty":-24.214551,"median":-9.744333,"eighty":-6.228791,"marketCap":642642577},{"date":"2021-06-04","current":-18.629338,"twenty":-24.214551,"median":-9.744333,"eighty":-6.228791,"marketCap":604987739},{"date":"2021-06-11","current":-20.433008,"twenty":-24.214551,"median":-9.744333,"eighty":-6.228791,"marketCap":663561932},{"date":"2021-06-18","current":-20.149574,"twenty":-24.214551,"median":-9.744333,"eighty":-6.228791,"marketCap":654357416},{"date":"2021-06-25","current":-22.752013,"twenty":-24.214551,"median":-9.744333,"eighty":-6.228791,"marketCap":738871609},{"date":"2021-07-02","current":-20.664908,"twenty":-24.214551,"median":-9.744333,"eighty":-6.228791,"marketCap":671092900},{"date":"2021-07-09","current":-19.86614,"twenty":-24.214551,"median":-9.744333,"eighty":-6.228791,"marketCap":645152900},{"date":"2021-07-16","current":-17.779036,"twenty":-24.214551,"median":-9.744333,"eighty":-6.228791,"marketCap":577374191},{"date":"2021-07-23","current":-17.186401,"twenty":-24.214551,"median":-9.744333,"eighty":-6.228791,"marketCap":558128384},{"date":"2021-07-30","current":-15.954947,"twenty":-24.214551,"median":-9.744333,"eighty":-6.228791,"marketCap":570006437},{"date":"2021-08-06","current":-16.083156,"twenty":-24.214551,"median":-9.744333,"eighty":-6.228791,"marketCap":574586836},{"date":"2021-08-13","current":-15.167473,"twenty":-24.214551,"median":-9.744333,"eighty":-6.228791,"marketCap":541873133},{"date":"2021-08-20","current":-14.533538,"twenty":-24.214551,"median":-9.744333,"eighty":-6.228791,"marketCap":519225185},{"date":"2021-08-27","current":-15.777928,"twenty":-24.214551,"median":-9.744333,"eighty":-6.228791,"marketCap":563682268},{"date":"2021-09-03","current":-16.317947,"twenty":-24.214551,"median":-9.744333,"eighty":-6.228791,"marketCap":582974965},{"date":"2021-09-10","current":-14.791808,"twenty":-24.214551,"median":-9.744333,"eighty":-6.228791,"marketCap":528452127},{"date":"2021-09-17","current":-15.754449,"twenty":-24.214551,"median":-9.744333,"eighty":-6.228791,"marketCap":562843455},{"date":"2021-09-24","current":-14.603975,"twenty":-24.214551,"median":-9.744333,"eighty":-6.228791,"marketCap":521741623},{"date":"2021-10-01","current":-14.016999,"twenty":-24.214551,"median":-9.744333,"eighty":-6.228791,"marketCap":500771301},{"date":"2021-10-08","current":-15.050077,"twenty":-24.214551,"median":-9.744333,"eighty":-6.228791,"marketCap":537679068},{"date":"2021-10-15","current":-14.932682,"twenty":-24.214551,"median":-9.744333,"eighty":-6.228791,"marketCap":533485004},{"date":"2021-10-22","current":-14.416143,"twenty":-24.214551,"median":-9.744333,"eighty":-6.228791,"marketCap":515031120},{"date":"2021-10-29","current":-15.23791,"twenty":-24.214551,"median":-9.744333,"eighty":-6.228791,"marketCap":544389572},{"date":"2021-11-05","current":-15.777928,"twenty":-24.214551,"median":-9.744333,"eighty":-6.228791,"marketCap":563682268},{"date":"2021-11-12","current":-14.831828,"twenty":-24.214551,"median":-9.744333,"eighty":-6.228791,"marketCap":506076796},{"date":"2021-11-19","current":-11.900836,"twenty":-24.214551,"median":-9.744333,"eighty":-6.228791,"marketCap":406068434},{"date":"2021-11-26","current":-11.471294,"twenty":-24.214551,"median":-9.744333,"eighty":-6.228791,"marketCap":391412036},{"date":"2021-12-03","current":-10.511142,"twenty":-24.214551,"median":-9.744333,"eighty":-6.228791,"marketCap":358650676},{"date":"2021-12-10","current":-10.991218,"twenty":-24.214551,"median":-9.744333,"eighty":-6.228791,"marketCap":375031356},{"date":"2021-12-17","current":-11.117554,"twenty":-24.214551,"median":-9.744333,"eighty":-6.228791,"marketCap":379342062},{"date":"2021-12-23","current":-11.521829,"twenty":-24.214551,"median":-9.744333,"eighty":-6.228791,"marketCap":393136318},{"date":"2021-12-31","current":-10.864882,"twenty":-24.214551,"median":-9.744333,"eighty":-6.228791,"marketCap":370720651},{"date":"2022-01-07","current":-10.43534,"twenty":-24.208916,"median":-9.744333,"eighty":-6.228791,"marketCap":356064253},{"date":"2022-01-14","current":-9.828928,"twenty":-24.208916,"median":-9.736096,"eighty":-6.228791,"marketCap":335372868},{"date":"2022-01-21","current":-9.247784,"twenty":-24.208916,"median":-9.640531,"eighty":-6.228791,"marketCap":315543624},{"date":"2022-01-28","current":-8.489769,"twenty":-24.208916,"median":-9.623385,"eighty":-6.228791,"marketCap":289679392},{"date":"2022-02-04","current":-7.959158,"twenty":-24.208916,"median":-9.579271,"eighty":-6.228791,"marketCap":271574430},{"date":"2022-02-11","current":-7.858089,"twenty":-24.208916,"median":-9.579271,"eighty":-6.228791,"marketCap":268125866},{"date":"2022-02-18","current":-7.276944,"twenty":-24.208916,"median":-9.537007,"eighty":-6.228791,"marketCap":248296622},{"date":"2022-02-25","current":-7.612391,"twenty":-24.208916,"median":-9.490142,"eighty":-6.228791,"marketCap":260366597},{"date":"2022-03-04","current":-7.381254,"twenty":-24.208916,"median":-9.476304,"eighty":-6.228791,"marketCap":252461015},{"date":"2022-03-11","current":-8.038488,"twenty":-24.208916,"median":-9.461802,"eighty":-6.228791,"marketCap":274940421},{"date":"2022-03-18","current":-8.291271,"twenty":-24.208916,"median":-9.439344,"eighty":-6.228791,"marketCap":283586346},{"date":"2022-03-25","current":-8.240715,"twenty":-24.208916,"median":-9.40628,"eighty":-6.228791,"marketCap":281857161},{"date":"2022-04-01","current":-8.341828,"twenty":-24.208916,"median":-9.367061,"eighty":-6.228791,"marketCap":285315531},{"date":"2022-04-08","current":-7.305419,"twenty":-24.208916,"median":-9.367061,"eighty":-6.228791,"marketCap":249867238},{"date":"2022-04-14","current":-6.597627,"twenty":-24.208916,"median":-9.367061,"eighty":-6.228791,"marketCap":225658647},{"date":"2022-04-22","current":-6.11734,"twenty":-24.208916,"median":-9.367061,"eighty":-6.228486,"marketCap":209231389},{"date":"2022-04-29","current":-6.016227,"twenty":-24.208916,"median":-9.367061,"eighty":-6.227268,"marketCap":205773019},{"date":"2022-05-06","current":-5.257879,"twenty":-24.208916,"median":-9.367061,"eighty":-6.214032,"marketCap":179835244},{"date":"2022-05-13","current":-4.878705,"twenty":-24.208916,"median":-9.367061,"eighty":-6.155471,"marketCap":166866356},{"date":"2022-05-20","current":-4.75414,"twenty":-24.208916,"median":-9.367061,"eighty":-6.148147,"marketCap":161678801},{"date":"2022-05-27","current":-4.75414,"twenty":-24.208916,"median":-9.367061,"eighty":-6.146395,"marketCap":161678801},{"date":"2022-06-03","current":-4.601601,"twenty":-24.208916,"median":-9.367061,"eighty":-6.146395,"marketCap":156491246},{"date":"2022-06-10","current":-4.245676,"twenty":-24.208916,"median":-9.367061,"eighty":-6.140746,"marketCap":144386950},{"date":"2022-06-17","current":-4.398215,"twenty":-24.208916,"median":-9.367061,"eighty":-6.12288,"marketCap":149574505},{"date":"2022-06-24","current":-5.313451,"twenty":-24.214551,"median":-9.375115,"eighty":-6.120664,"marketCap":180699836},{"date":"2022-07-01","current":-4.881256,"twenty":-24.214551,"median":-9.375115,"eighty":-6.066279,"marketCap":166001763},{"date":"2022-07-08","current":-5.898185,"twenty":-24.214551,"median":-9.375115,"eighty":-6.062176,"marketCap":200585464},{"date":"2022-07-15","current":-4.75414,"twenty":-24.214551,"median":-9.375115,"eighty":-6.018683,"marketCap":161678801},{"date":"2022-07-22","current":-4.703294,"twenty":-24.214551,"median":-9.375115,"eighty":-6.018683,"marketCap":159949616},{"date":"2022-07-29","current":-4.093137,"twenty":-24.214551,"median":-9.375115,"eighty":-6.008028,"marketCap":139199395},{"date":"2022-08-05","current":-3.757896,"twenty":-24.214551,"median":-9.375115,"eighty":-5.997779,"marketCap":126471978},{"date":"2022-08-12","current":-3.860852,"twenty":-24.214551,"median":-9.375115,"eighty":-5.997779,"marketCap":129936964},{"date":"2022-08-19","current":-3.526245,"twenty":-24.214551,"median":-9.375115,"eighty":-5.997779,"marketCap":118675760},{"date":"2022-08-26","current":-3.165898,"twenty":-24.214551,"median":-9.375115,"eighty":-5.997779,"marketCap":106548310},{"date":"2022-09-02","current":-2.934247,"twenty":-24.214551,"median":-9.375115,"eighty":-5.997779,"marketCap":98752093},{"date":"2022-09-09","current":-2.676857,"twenty":-24.214551,"median":-9.375115,"eighty":-5.997779,"marketCap":90089628},{"date":"2022-09-16","current":-2.573901,"twenty":-24.214551,"median":-9.375115,"eighty":-5.997779,"marketCap":86624643},{"date":"2022-09-23","current":-1.973153,"twenty":-24.214551,"median":-9.375115,"eighty":-5.997779,"marketCap":66406451},{"date":"2022-09-30","current":-1.691053,"twenty":-24.214551,"median":-9.375115,"eighty":-5.960059,"marketCap":56912390},{"date":"2022-10-07","current":-1.487715,"twenty":-24.214551,"median":-9.375115,"eighty":-5.960059,"marketCap":50069043},{"date":"2022-10-14","current":-1.960798,"twenty":-24.214551,"median":-9.375115,"eighty":-5.938611,"marketCap":65990653},{"date":"2022-10-21","current":-2.136338,"twenty":-24.214551,"median":-9.375115,"eighty":-5.91186,"marketCap":71898453},{"date":"2022-10-28","current":-2.252163,"twenty":-24.214551,"median":-9.375115,"eighty":-5.91186,"marketCap":75796562},{"date":"2022-11-04","current":-2.170056,"twenty":-24.214551,"median":-9.375115,"eighty":-5.91186,"marketCap":73033236},{"date":"2022-11-11","current":-2.367989,"twenty":-24.214551,"median":-9.375115,"eighty":-5.91186,"marketCap":79694671},{"date":"2022-11-18","current":-2.251309,"twenty":-24.214551,"median":-9.375115,"eighty":-5.91186,"marketCap":88357135},{"date":"2022-11-25","current":-2.154856,"twenty":-24.214551,"median":-9.375115,"eighty":-5.91186,"marketCap":84571638},{"date":"2022-12-02","current":-2.560313,"twenty":-24.214551,"median":-9.375115,"eighty":-5.91186,"marketCap":100484585},{"date":"2022-12-09","current":-2.295453,"twenty":-24.214551,"median":-9.375115,"eighty":-5.91186,"marketCap":90089628},{"date":"2022-12-16","current":-1.781624,"twenty":-24.214551,"median":-9.375115,"eighty":-5.91186,"marketCap":69923411},{"date":"2022-12-23","current":-1.674798,"twenty":-24.214551,"median":-9.375115,"eighty":-5.91186,"marketCap":65730779},{"date":"2022-12-30","current":-1.579669,"twenty":-24.214551,"median":-9.375115,"eighty":-5.91186,"marketCap":61997256},{"date":"2023-01-06","current":-1.915599,"twenty":-24.214551,"median":-9.375115,"eighty":-5.91186,"marketCap":75181527},{"date":"2023-01-13","current":-2.339596,"twenty":-24.214551,"median":-9.375115,"eighty":-5.91186,"marketCap":91822121},{"date":"2023-01-20","current":-1.909199,"twenty":-24.214551,"median":-9.375115,"eighty":-5.91186,"marketCap":74930316},{"date":"2023-01-27","current":-1.916482,"twenty":-24.214551,"median":-9.375115,"eighty":-5.91186,"marketCap":75216177},{"date":"2023-02-03","current":-2.118879,"twenty":-24.214551,"median":-9.375115,"eighty":-5.91186,"marketCap":83159657},{"date":"2023-02-10","current":-1.800827,"twenty":-24.214551,"median":-9.375115,"eighty":-5.91186,"marketCap":70677046},{"date":"2023-02-17","current":-1.787804,"twenty":-24.214551,"median":-9.375115,"eighty":-5.91186,"marketCap":70165960},{"date":"2023-02-24","current":-1.645221,"twenty":-24.214551,"median":-9.375115,"eighty":-5.91186,"marketCap":64570008},{"date":"2023-03-03","current":-2.163431,"twenty":-24.214551,"median":-9.375115,"eighty":-5.91186,"marketCap":72894637},{"date":"2023-03-10","current":-1.902739,"twenty":-24.214551,"median":-9.375115,"eighty":-5.91186,"marketCap":64110898},{"date":"2023-03-17","current":-1.748484,"twenty":-24.214551,"median":-9.375115,"eighty":-5.864414,"marketCap":58913419},{"date":"2023-03-24","current":-1.799645,"twenty":-24.214551,"median":-9.375115,"eighty":-5.853124,"marketCap":60637250},{"date":"2023-03-31","current":-1.804787,"twenty":-24.208916,"median":-9.367061,"eighty":-5.834223,"marketCap":60810499},{"date":"2023-04-06","current":-1.691667,"twenty":-24.208916,"median":-9.367061,"eighty":-5.768824,"marketCap":56999015},{"date":"2023-04-14","current":-1.604255,"twenty":-24.214551,"median":-9.375115,"eighty":-5.725565,"marketCap":54053777},{"date":"2023-04-21","current":-1.593972,"twenty":-24.220187,"median":-9.388924,"eighty":-5.618675,"marketCap":53707278},{"date":"2023-04-28","current":-1.510417,"twenty":-24.220187,"median":-9.388924,"eighty":-5.48244,"marketCap":50891977},{"date":"2023-05-05","current":-1.619681,"twenty":-24.220187,"median":-9.388924,"eighty":-5.48244,"marketCap":54573525},{"date":"2023-05-12","current":-1.928191,"twenty":-24.220187,"median":-9.388924,"eighty":-5.375064,"marketCap":64968482},{"date":"2023-05-19","current":-1.953901,"twenty":-24.220187,"median":-9.388924,"eighty":-5.280108,"marketCap":65834728},{"date":"2023-05-26","current":-2.489064,"twenty":-24.220187,"median":-9.388924,"eighty":-4.967695,"marketCap":82943095},{"date":"2023-06-02","current":-2.677531,"twenty":-24.220187,"median":-9.388924,"eighty":-4.916849,"marketCap":89223382},{"date":"2023-06-09","current":-3.301422,"twenty":-24.220187,"median":-9.388924,"eighty":-4.864982,"marketCap":110013296},{"date":"2023-06-16","current":-3.561377,"twenty":-24.220187,"median":-9.388924,"eighty":-4.764309,"marketCap":118675760},{"date":"2023-06-23","current":-2.729522,"twenty":-24.225822,"median":-9.402733,"eighty":-4.75414,"marketCap":90955875},{"date":"2023-06-30","current":-2.911491,"twenty":-24.231457,"median":-9.40628,"eighty":-4.703294,"marketCap":97019600},{"date":"2023-07-07","current":-2.963481,"twenty":-24.231457,"median":-9.40628,"eighty":-4.576178,"marketCap":98752093},{"date":"2023-07-14","current":-3.405404,"twenty":-24.231457,"median":-9.40628,"eighty":-4.398215,"marketCap":113478282},{"date":"2023-07-21","current":-2.989477,"twenty":-24.231457,"median":-9.40628,"eighty":-4.321946,"marketCap":99618339},{"date":"2023-07-28","current":-2.677531,"twenty":-24.231457,"median":-9.40628,"eighty":-4.245676,"marketCap":89223382},{"date":"2023-08-04","current":-2.911491,"twenty":-24.231457,"median":-9.40628,"eighty":-4.04229,"marketCap":97019600},{"date":"2023-08-11","current":-2.824992,"twenty":-24.231457,"median":-9.40628,"eighty":-3.809374,"marketCap":94510111},{"date":"2023-08-18","current":-2.79859,"twenty":-24.231457,"median":-9.40628,"eighty":-3.706418,"marketCap":93626839},{"date":"2023-08-25","current":-3.115412,"twenty":-24.231457,"median":-9.40628,"eighty":-3.551984,"marketCap":104226104},{"date":"2023-09-01","current":-3.009805,"twenty":-24.231457,"median":-9.40628,"eighty":-3.405404,"marketCap":100693015},{"date":"2023-09-08","current":-2.851394,"twenty":-24.231457,"median":-9.40628,"eighty":-3.301422,"marketCap":95393383},{"date":"2023-09-15","current":-2.772189,"twenty":-24.231457,"median":-9.40628,"eighty":-3.268854,"marketCap":92743567},{"date":"2023-09-22","current":-2.587376,"twenty":-24.231457,"median":-9.40628,"eighty":-3.165898,"marketCap":86560662},{"date":"2023-09-29","current":-2.323358,"twenty":-24.231457,"median":-9.40628,"eighty":-3.093459,"marketCap":77727942},{"date":"2023-10-06","current":-2.34712,"twenty":-24.231457,"median":-9.40628,"eighty":-3.036206,"marketCap":78522887},{"date":"2023-10-13","current":-2.122704,"twenty":-24.231457,"median":-9.40628,"eighty":-3.009805,"marketCap":71015074},{"date":"2023-10-20","current":-1.953733,"twenty":-24.231457,"median":-9.40628,"eighty":-2.989477,"marketCap":65362133},{"date":"2023-10-27","current":-1.861327,"twenty":-24.282174,"median":-9.428082,"eighty":-2.963481,"marketCap":62270680},{"date":"2023-11-03","current":-2.0002,"twenty":-24.282174,"median":-9.428082,"eighty":-2.919134,"marketCap":66916692},{"date":"2023-11-10","current":-1.665284,"twenty":-24.282174,"median":-9.428082,"eighty":-2.911491,"marketCap":52554688},{"date":"2023-11-17","current":-1.713703,"twenty":-24.282174,"median":-9.428082,"eighty":-2.854636,"marketCap":54082748},{"date":"2023-11-24","current":-1.791509,"twenty":-24.282174,"median":-9.428082,"eighty":-2.824992,"marketCap":56538245},{"date":"2023-12-01","current":-1.854762,"twenty":-24.282174,"median":-9.428082,"eighty":-2.772189,"marketCap":58534440},{"date":"2023-12-08","current":-2.25611,"twenty":-24.265268,"median":-9.418955,"eighty":-2.765521,"marketCap":71200561},{"date":"2023-12-15","current":-2.166268,"twenty":-24.265268,"median":-9.418955,"eighty":-2.729522,"marketCap":68365258},{"date":"2023-12-22","current":-4.869905,"twenty":-24.265268,"median":-9.418955,"eighty":-2.724755,"marketCap":153689340},{"date":"2023-12-29","current":-4.981857,"twenty":-24.282174,"median":-9.428082,"eighty":-2.722965,"marketCap":157222428},{"date":"2024-01-05","current":-5.177773,"twenty":-24.299079,"median":-9.42865,"eighty":-2.721175,"marketCap":163405332},{"date":"2024-01-12","current":-5.065821,"twenty":-24.299079,"median":-9.42865,"eighty":-2.721175,"marketCap":159872244},{"date":"2024-01-19","current":-5.401677,"twenty":-24.315985,"median":-9.429219,"eighty":-2.719385,"marketCap":170471509},{"date":"2024-01-26","current":-5.90546,"twenty":-24.299079,"median":-9.367061,"eighty":-2.721175,"marketCap":186370406},{"date":"2024-02-02","current":-6.773087,"twenty":-24.299079,"median":-9.352717,"eighty":-2.721175,"marketCap":213751840},{"date":"2024-02-09","current":-5.989424,"twenty":-24.299079,"median":-9.352717,"eighty":-2.721175,"marketCap":189020222},{"date":"2024-02-16","current":-6.493207,"twenty":-24.299079,"median":-9.325915,"eighty":-2.721175,"marketCap":204919120},{"date":"2024-02-23","current":-6.493207,"twenty":-24.299079,"median":-9.306645,"eighty":-2.721175,"marketCap":204919120},{"date":"2024-03-01","current":-7.220894,"twenty":-24.282174,"median":-9.303802,"eighty":-2.722965,"marketCap":227884194},{"date":"2024-03-08","current":-12.480916,"twenty":-24.282174,"median":-9.306645,"eighty":-2.722965,"marketCap":234067098},{"date":"2024-03-15","current":-12.794119,"twenty":-24.282174,"median":-9.306645,"eighty":-2.722965,"marketCap":239940917},{"date":"2024-03-22","current":-12.74638,"twenty":-24.282174,"median":-9.306645,"eighty":-2.722965,"marketCap":239045615},{"date":"2024-03-28","current":-12.12577,"twenty":-24.282174,"median":-9.306645,"eighty":-2.722965,"marketCap":227406690},{"date":"2024-04-05","current":-11.075506,"twenty":-24.299079,"median":-9.306645,"eighty":-2.721175,"marketCap":207710047},{"date":"2024-04-12","current":-10.789071,"twenty":-24.299079,"median":-9.306645,"eighty":-2.721175,"marketCap":202338236},{"date":"2024-04-19","current":-8.974979,"twenty":-24.299079,"median":-9.318163,"eighty":-2.721175,"marketCap":168316762},{"date":"2024-04-26","current":-9.070458,"twenty":-24.282174,"median":-9.329681,"eighty":-2.722965,"marketCap":170107366},{"date":"2024-05-03","current":-10.311678,"twenty":-24.282174,"median":-9.352717,"eighty":-2.722965,"marketCap":193385216},{"date":"2024-05-10","current":-9.977504,"twenty":-24.282174,"median":-9.356893,"eighty":-2.722965,"marketCap":187118103},{"date":"2024-05-17","current":-10.2162,"twenty":-24.282174,"median":-9.467898,"eighty":-2.722965,"marketCap":191594613},{"date":"2024-05-24","current":-12.182804,"twenty":-24.282174,"median":-9.537007,"eighty":-2.722965,"marketCap":203233538},{"date":"2024-05-31","current":-11.753454,"twenty":-24.282174,"median":-9.606116,"eighty":-2.722965,"marketCap":196071122},{"date":"2024-06-07","current":-11.538779,"twenty":-24.282174,"median":-9.691068,"eighty":-2.722965,"marketCap":192489914},{"date":"2024-06-14","current":-11.002092,"twenty":-24.299079,"median":-9.744333,"eighty":-2.721175,"marketCap":183536895},{"date":"2024-06-21","current":-9.982386,"twenty":-24.315985,"median":-9.836478,"eighty":-2.719385,"marketCap":166526158},{"date":"2024-06-28","current":-9.445698,"twenty":-24.349796,"median":-9.917105,"eighty":-2.709312,"marketCap":157573139},{"date":"2024-07-05","current":-8.96268,"twenty":-24.349796,"median":-9.917105,"eighty":-2.709312,"marketCap":149515422},{"date":"2024-07-12","current":-9.39203,"twenty":-24.349796,"median":-9.917105,"eighty":-2.709312,"marketCap":156677837},{"date":"2024-07-15","current":-9.445698,"twenty":-24.349796,"median":-9.917105,"eighty":-2.709312,"marketCap":157573139},{"date":"2024-08-02","current":-9.767711,"twenty":-24.484945,"median":-9.982386,"eighty":-2.700673,"marketCap":162944951},{"date":"2024-08-09","current":-16.443358,"twenty":-24.484945,"median":-10.020768,"eighty":-2.700673,"marketCap":156688756},{"date":"2024-08-16","current":-17.00713,"twenty":-24.484945,"median":-10.168461,"eighty":-2.700673,"marketCap":162060941},{"date":"2024-08-23","current":-19.168257,"twenty":-24.484945,"median":-10.334272,"eighty":-2.700673,"marketCap":182654321},{"date":"2024-08-30","current":-19.074295,"twenty":-24.484945,"median":-10.43534,"eighty":-2.700673,"marketCap":181758956},{"date":"2024-09-06","current":-17.101092,"twenty":-24.484945,"median":-10.550375,"eighty":-2.700673,"marketCap":162956306},{"date":"2024-09-13","current":-18.416561,"twenty":-24.484945,"median":-10.688012,"eighty":-2.700673,"marketCap":175491406},{"date":"2024-09-20","current":-17.289016,"twenty":-24.484945,"median":-10.864882,"eighty":-2.700673,"marketCap":164747034},{"date":"2024-09-27","current":-16.442532,"twenty":-24.484945,"median":-10.948458,"eighty":-2.700673,"marketCap":156680889},{"date":"2024-10-04","current":-16.725244,"twenty":-24.484945,"median":-11.075506,"eighty":-2.700673,"marketCap":159374848},{"date":"2024-10-11","current":-16.161472,"twenty":-24.484945,"median":-11.109429,"eighty":-2.700673,"marketCap":154002663},{"date":"2024-10-18","current":-16.255434,"twenty":-24.484945,"median":-11.170985,"eighty":-2.700673,"marketCap":154898027},{"date":"2024-10-25","current":-16.161472,"twenty":-24.484945,"median":-11.194031,"eighty":-2.700673,"marketCap":154002663},{"date":"2024-10-31","current":-15.409775,"twenty":-24.484945,"median":-11.266463,"eighty":-2.700673,"marketCap":146839748},{"date":"2024-11-08","current":-17.00713,"twenty":-24.506101,"median":-11.241615,"eighty":-2.698751,"marketCap":162060941},{"date":"2024-11-15","current":83.432947,"twenty":-24.506101,"median":-11.205399,"eighty":-2.692983,"marketCap":133409283},{"date":"2024-11-22","current":81.193137,"twenty":-24.506101,"median":-11.193356,"eighty":-2.677261,"marketCap":129827826},{"date":"2024-11-29","current":89.032474,"twenty":-24.506101,"median":-11.1204,"eighty":-2.651369,"marketCap":142362926},{"date":"2024-12-06","current":88.472522,"twenty":-24.506101,"median":-11.100858,"eighty":-2.625379,"marketCap":141467562},{"date":"2024-12-13","current":90.15238,"twenty":-24.506101,"median":-11.038799,"eighty":-2.553502,"marketCap":144153655},{"date":"2024-12-20","current":85.112806,"twenty":-24.506101,"median":-10.905086,"eighty":-2.475585,"marketCap":136095376},{"date":"2024-12-27","current":91.272285,"twenty":-24.506101,"median":-10.789071,"eighty":-2.449908,"marketCap":145944384},{"date":"2025-01-03","current":92.39219,"twenty":-24.506101,"median":-10.624845,"eighty":-2.423761,"marketCap":147735112},{"date":"2025-01-10","current":89.032474,"twenty":-24.527258,"median":-10.519073,"eighty":-2.361538,"marketCap":142362926},{"date":"2025-01-17","current":118.709966,"twenty":-24.527258,"median":-10.43534,"eighty":-2.322808,"marketCap":189817235},{"date":"2025-01-24","current":138.30831,"twenty":-24.527258,"median":-10.263939,"eighty":-2.298292,"marketCap":221154987},{"date":"2025-01-31","current":131.588877,"twenty":-24.527258,"median":-10.072982,"eighty":-2.263018,"marketCap":210410615},{"date":"2025-02-07","current":141.108073,"twenty":-24.527258,"median":-9.977504,"eighty":-2.23428,"marketCap":225631808},{"date":"2025-02-14","current":122.629635,"twenty":-24.527258,"median":-9.691068,"eighty":-2.213896,"marketCap":196084786},{"date":"2025-02-21","current":122.069682,"twenty":-24.527258,"median":-9.59559,"eighty":-2.189476,"marketCap":195189421},{"date":"2025-02-28","current":103.591244,"twenty":-24.527258,"median":-9.445698,"eighty":-2.172091,"marketCap":165642399},{"date":"2025-03-07","current":-10.507051,"twenty":-24.451134,"median":-9.39203,"eighty":-2.170365,"marketCap":149525841},{"date":"2025-03-14","current":-10.579432,"twenty":-24.299079,"median":-9.39203,"eighty":-2.170365,"marketCap":150555901},{"date":"2025-03-21","current":-10.513722,"twenty":-24.299079,"median":-9.39203,"eighty":-2.170365,"marketCap":149620771},{"date":"2025-03-28","current":-9.988035,"twenty":-24.299079,"median":-9.39203,"eighty":-2.170365,"marketCap":142139732},{"date":"2025-04-04","current":-9.265217,"twenty":-24.299079,"median":-9.374461,"eighty":-2.170365,"marketCap":131853304},{"date":"2025-04-11","current":-7.613302,"twenty":-24.18074,"median":-9.247784,"eighty":-2.170674,"marketCap":108344907},{"date":"2025-04-17","current":-9.52806,"twenty":-23.870803,"median":-9.177355,"eighty":-2.170674,"marketCap":135593823},{"date":"2025-04-25","current":-9.725192,"twenty":-23.369267,"median":-9.168959,"eighty":-2.170365,"marketCap":138399213}],"updateTime":1745869727142}}}